Literature DB >> 17486446

Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes.

Lilia Fisk1, Natalia N Nalivaeva, John P Boyle, Christopher S Peers, Anthony J Turner.   

Abstract

Pathogenesis of Alzheimer's disease (AD), which is characterised by accumulation of extracellular deposits of beta-amyloid peptide (Abeta) in the brain, has recently been linked to vascular disorders such as ischemia and stroke. Abeta is constantly produced in the brain from amyloid precursor protein (APP) through its cleavage by beta- and gamma-secretases and certain Abeta species are toxic for neurones. The brain has an endogenous mechanism of Abeta removal via proteolytic degradation and the zinc metalloproteinase neprilysin (NEP) is a critical regulator of Abeta concentration. Down-regulation of NEP could predispose to AD. By comparing the effects of hypoxia and oxidative stress on expression and activity of the Abeta-degrading enzyme NEP in human neuroblastoma NB7 cells and rat primary cortical neurones we have demonstrated that hypoxia reduced NEP expression at the protein and mRNA levels as well as its activity. On contrary in astrocytes hypoxia increased NEP mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486446     DOI: 10.1007/s11064-007-9349-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Effects of chronic hypoxia on Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells.

Authors:  I F Smith; J P Boyle; P F Vaughan; H A Pearson; C Peers
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

2.  Altered processing of amyloid precursor protein in the human neuroblastoma SH-SY5Y by chronic hypoxia.

Authors:  Nicola J Webster; Kim N Green; Chris Peers; Peter F T Vaughan
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

3.  Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.

Authors:  L Reznichenko; T Amit; H Zheng; Y Avramovich-Tirosh; M B H Youdim; O Weinreb; S Mandel
Journal:  J Neurochem       Date:  2006-03-15       Impact factor: 5.372

Review 4.  Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety.

Authors:  O Weinreb; T Amit; O Bar-Am; Y Sagi; S Mandel; M B H Youdim
Journal:  J Neural Transm Suppl       Date:  2006

5.  Determination of hypoxic effect on neprilysin activity in human neuroblastoma SH-SY5Y cells using a novel HPLC method.

Authors:  Kentaro Oh-hashi; Takeki Nagai; Tatsuhide Tanaka; Hai Yu; Yoko Hirata; Kazutoshi Kiuchi
Journal:  Biochem Biophys Res Commun       Date:  2005-08-26       Impact factor: 3.575

6.  Chronic hypoxia inhibits Na+/Ca2+ exchanger expression in cortical astrocytes.

Authors:  Lucy Atkinson; John P Boyle; Hugh A Pearson; Chris Peers
Journal:  Neuroreport       Date:  2006-04-24       Impact factor: 1.837

Review 7.  The role of cerebral ischemia in Alzheimer's disease.

Authors:  R N Kalaria
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

Review 8.  Disease modifying therapy for AD?

Authors:  Todd E Golde
Journal:  J Neurochem       Date:  2006-11       Impact factor: 5.372

9.  A zinc metalloendopeptidase associated with dog pancreatic membranes.

Authors:  R A Mumford; A W Strauss; J C Powers; P A Pierzchala; N Nishino; M Zimmerman
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

10.  Regulation of endothelin-converting enzyme-1 expression in human neuroblastoma cells.

Authors:  Lilia Fisk; Natalia N Nalivaeva; Anthony J Turner
Journal:  Exp Biol Med (Maywood)       Date:  2006-06
View more
  43 in total

1.  The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation period.

Authors:  Carlo Aldinucci; Silvia Maria Maiorca; Paola De Rosa; Mitri Palmi; Claudia Sticozzi; Lucia Ciccoli; Silvia Leoncini; Cinzia Signorini; Giuseppe Valacchi; Gian Paolo Pessina
Journal:  Neurochem Res       Date:  2010-07-18       Impact factor: 3.996

2.  Epigenetic and pharmacological regulation of the amyloid-degrading enzyme neprilysin results in modulation of cognitive functions in mammals.

Authors:  I A Zhuravin; N M Dubrovskaya; D S Vasilev; N L Tumanova; N N Nalivaeva
Journal:  Dokl Biol Sci       Date:  2011-07-05

Review 3.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

4.  Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia.

Authors:  Jiejie Li; Wenli Sheng; Chenzhuo Feng; Zhiyi Zuo
Journal:  Neurobiol Dis       Date:  2011-09-24       Impact factor: 5.996

5.  Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

Authors:  Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

6.  C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively.

Authors:  Huiping Xie; Zhimin Xiao; Jian Huang
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

7.  Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.

Authors:  Nikolai D Belyaev; Natalia N Nalivaeva; Natalia Z Makova; Anthony J Turner
Journal:  EMBO Rep       Date:  2008-12-05       Impact factor: 8.807

8.  Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.

Authors:  Mirna Ezzat Sorial; Nesrine Salah El Dine El Sayed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

Review 9.  The role of metals in modulating metalloprotease activity in the AD brain.

Authors:  Gulay Filiz; Katherine A Price; Aphrodite Caragounis; Tai Du; Peter J Crouch; Anthony R White
Journal:  Eur Biophys J       Date:  2008-02-13       Impact factor: 1.733

10.  Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid.

Authors:  Yo-El S Ju; Mary Beth Finn; Courtney L Sutphen; Elizabeth M Herries; Gina M Jerome; Jack H Ladenson; Daniel L Crimmins; Anne M Fagan; David M Holtzman
Journal:  Ann Neurol       Date:  2016-06-01       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.